Clinical Trial Update: Innovating Shorter, All- Oral, Precised Treatment Regimen for Rifampicin Resistant Tuberculosis：BDLL Chinese Cohort [Phase 3]

View source ↗

Summary

This update describes a Phase 3 clinical trial evaluating a shorter, all-oral, precise treatment regimen for rifampicin-resistant tuberculosis in the BDLL Chine…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Drug-resistant Tuberculosis
• Pulmonary Tuberculosis
• Rifampin-resistant Tuberculosis

Snippet

Sponsor: Huashan Hospital | Conditions: Drug-resistant Tuberculosis, Pulmonary Tuberculosis | Phase 3 | Status: ACTIVE_NOT_RECRUITING